; (ii) the average TRICARE amount paid per prescription; and (iii) the average beneficiary out-of-pocket cost per prescription. (c) Definitions In this section: (1) The term affected beneficiary means a beneficiary who filled at least one prescription in the year preceding October 24, 2022, at a departed pharmacy. (2) The term beneficiary has the meaning given that term in section 1074g(i) of title 10, United States Code. (3) The term departed retail pharmacy means a retail pharmacy that participated in the TRICARE network in September 2022 but left the network with the transition to the TPharm5 contract. (4) The term network pharmacy means a retail pharmacy described in section 1074g(a)(2)(E)(ii) of title 10, United States Code. (5) The term rural — (A) with regards to a location, has the meaning given such term in section 343(a) of the Consolidated Farm and Rural Development Act ( 7 U.S.C. 1991(a) ); and (B) with regards to a beneficiary, has the meaning used by the Secretary of Defense in the administration of section 1074g of title 10, United States Code. (6) The term TPharm4 means the period covered by the 4th Generation pharmacy contract under TRICARE prior to October 24, 2022, when the retail network reduction went into effect. (7) The term TPharm5 means the period covered by the 5th Generation pharmacy contract under TRICARE to date.